









Markets
/
Stocks
/
nasdaq-avte
/

Aerovate Therapeutics Inc

AVTE

2.680USD

0.000

Close 08/04, 16:00（ET）Quotes delayed by 15 min

77.68MMarket Cap

LossP/E TTM



Aerovate Therapeutics Inc

2.680

0.000

Overview Company Financials

Income Statement

Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

Total equity

Cash, cash equivalents and short-term investments

--76.21M

--78.62M

- Cash and cash equivalents

--44.22M

--33.75M

-Short-term investments

--31.99M

--44.87M

Prepaid expenses

--318.00K

--649.00K

Other current assets

--845.00K

--845.00K

Total current assets

--77.37M

--80.12M

Non-current assets

Net Fixed Assets

--160.00K

--215.00K

Other non-current assets

--0.00

--0.00

Total assets

--77.53M

--80.33M

Liabilities

Current liabilities

-Other payables

--318.00K

--649.00K

Accrued expenses

--1.72M

--2.54M

Other current liabilities

--318.00K

--649.00K

Total current liabilities

--2.42M

--3.83M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

--0.00

Other non-current liabilities

--70.00K

--70.00K

Total liabilities

--2.49M

--3.90M

Shareholders' equity

Common equity

--310.57M

--309.38M

Retained earnings

---235.57M

---233.05M

Capital reserves

--310.56M

--309.38M

Gains losses not affecting retained earnings

--50.00K

--105.00K

Total equity

--75.05M

--76.43M

Currency unit

USD

USD

Audit opinions

--

--

KeyAI

